Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-948-4 | CAS number: 16903-35-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- The process for gold analysis was undertaken on plasma and urine samples taken from rats on the oral Maximum Tolerated Dose (MTD) study with the test substance.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2017
Materials and methods
- Objective of study:
- absorption
- Principles of method if other than guideline:
- Blood samples were taken into an appropriate anticoagulant from rats at termination of the MTD study and the plasma was separated by centrifugation and stored frozen until anaysis. In addition, overnight urine samples were collected from the same animals and stored frozen until analysis. All sample analysis was undertaken using inductively coupled plasma–mass spectrometry (ICP–MS). ( Nexion 300D PerkinElmer, Waltham, MA ). Samples were analysed in the standard mode.
To 500 µl of the sample ( urine and whole blood ) was added 100 µl HCl 37% and 400 µl HNO3 70%. Samples were then incubated during one hour at 80 °C. After incubation samples were further diluted
with HNO3 0.7% ( 20-fold dilution ). Rhodium was used as internal standard. - GLP compliance:
- yes
Test material
- Specific details on test material used for the study:
- Tetrachloroauric acid (orange liquid)
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- other: HsdHan:WIST
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan, Bicester, UK
- Age at study initiation: At least 9 weeks
- Weight at study initiation: N/A
- Housing: 5 per cage
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
- Acclimation period: At least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20 to 24
- Humidity (%): 45-65
- Air changes (per hr): 15-20
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 28 October 2013 To: 12 November 2013
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Dose solutions were prepared freshly each day
Doses / concentrationsopen allclose all
- Dose / conc.:
- 80 mg/kg bw/day (nominal)
- Remarks:
- Actual dose received was adjusted for density to 168 mg/kg/day
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- Remarks:
- Actual dose received was adjusted for density to 210 mg/kg/day
- No. of animals per sex per dose / concentration:
- 5 male and 5 female rats per group
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale:
- Initial dose levels were based on acute studies and subsequent doseselection was based upon the reactions seen at the previous dose level - Details on dosing and sampling:
- Animals were dosed each day for 14 consecutive days and at the end of the treatment period overnight urine samples and blood samples were collected from each animal
Results and discussion
Main ADME results
- Type:
- absorption
- Results:
- Significant increases in gold content over the controls were measured in both the plasma and urine of rats treated with either 80 (168) or 100 (210) mg/kg/day tetrachloroauric acid
Applicant's summary and conclusion
- Conclusions:
- Analysis for gold in the urine and plasma of rats treated by daily oral gavage at 80 (actual dose: 168) or 100 (actual dose: 210) mg/kg/day tetrachloroauric acid for 14 days showed significant systemic exposure to gold in comparison with the control animals and that there was no dose relationship at these treatment levels.
- Executive summary:
A GLP compliant, non-regulatory Maximum Tolerated Dose study was conducted in rats by the oral gavage route in order to determine suitable dose levels to be used in subsequent repeat dose regulatory studies with the test substance. At the end of the "fixed dose" phase in which animals were dosed for 14 consecutive days at nominal dose levels of 80 and 100 mg/kg/day (Adjusted for density of the solution to 168 and 210 mg/kg/day respectively), overnight urien samples were collected and also blood samples taken from each of the five male and five female rats per group including vehicle controls. Upon analysis of the plasma and urine samples for gold content, it was demonstrated that significant exposure had been achieved at these dose levels although there was no dose dependeny in the gold concentrations between the two treated groups.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.